Chinese Traditional and Herbal Drugs
|
2025, 56(20): 7605-7613
Research progress on ginsenosides and their preparations in treatment of sepsis
Full
SHI Ruoyu1,2, PANG Shuchao1,2, XIAO Lu1,2, WANG Kai1,2, WANG Shuang1,2, ZHANG Yaqian1,2, LIU Yi1,2
Affiliations
1 First Teaching Hospital of Tianjin University of traditional Chinese Medicine, Tianjin 300381, China;
2 National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China
doi: 10.7501/j.issn.0253-2670.2025.20.029
Outline
Sepsis is a life-threatening organ dysfunction syndrome triggered by a dysregulated host response to infection, posing a significant challenge to global public health due to its high morbidity and mortality rates. Current treatments primarily focus on symptomatic and supportive care but are limited by efficacy constraints and side effects. Ginsenosides, the core bioactive components of Renshen (Ginseng Radix et Rhizoma), exhibit various pharmacological activities, including anti-inflammatory, immunomodulatory, and antioxidant properties. In recent years, their multi-target and multi-pathway mechanisms in sepsis treatment have garnered increasing attention. This review summarizes the pathogenesis and pathological characteristics of sepsis, elaborates on the research progress of ginsenosides in regulating inflammatory responses, correcting immune dysfunction, improving coagulation and microcirculatory disturbances, inhibiting oxidative stress, coordinating the neuro-endocrine-immune network, alleviating mitochondrial damage, and mitigating endoplasmic reticulum stress. In addition, traditional Chinese medicine compound preparations represented by Shenmai Injection (参麦注射液), through the synergistic effect of ginsenosides and other active ingredients, have demonstrated integrated advantages in improving organ function and restoring immune homeostasis in clinical and experimental studies. This article aims to provide theoretical basis and research direction for ginsenosides and their preparations as new strategies for treatment of sepsis. In the future, it is necessary to further verify its efficacy by deepening the molecular mechanism analysis, clarifying the pharmacokinetic characteristics and conducting high-quality clinical trials, and promote its transformation and application in the precise treatment of sepsis with integrated traditional Chinese medicine and Western medicine.
ginsenosides
/
sepsis
/
inflammatory response
/
correction of immune dysfunction
/
inhibition of oxidative stress
/
coagulation function
史若愚, 庞树朝, 肖璐, 王凯, 王双, 张亚乾, 刘毅.
人参皂苷及其制剂治疗脓毒症的研究进展.
中草药,
2025
, 56
(20)
: 7605
-7613
.
DOI: 10.7501/j.issn.0253-2670.2025.20.029
SHI Ruoyu, PANG Shuchao, XIAO Lu, WANG Kai, WANG Shuang, ZHANG Yaqian, LIU Yi.
Research progress on ginsenosides and their preparations in treatment of sepsis[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(20)
: 7605
-7613
.
DOI: 10.7501/j.issn.0253-2670.2025.20.029
Year 2025 volume 56 Issue 20
58
13
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.20.029
- Receive Date:2025-05-30
- Online Date:2026-11-13